.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chubb
McKinsey
UBS
Novartis
Boehringer Ingelheim
Harvard Business School
Argus Health
Mallinckrodt
Dow

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091577

« Back to Dashboard

NDA 091577 describes METHYLERGONOVINE MALEATE, which is a drug marketed by Breckenridge Pharm, Luitpold, and Novel Labs Inc, and is included in three NDAs. It is available from ten suppliers. Additional details are available on the METHYLERGONOVINE MALEATE profile page.

The generic ingredient in METHYLERGONOVINE MALEATE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.

Summary for 091577

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 091577

Ingredient-typeErgolines

Medical Subject Heading (MeSH) Categories for 091577

Suppliers and Packaging for NDA: 091577

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 091577 ANDA KAISER FOUNDATION HOSPITALS 0179-0122 0179-0122-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0122-70)
METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 091577 ANDA Lupin Pharma 27437-050 27437-050-56 28 TABLET in 1 BOTTLE (27437-050-56)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.2MG
Approval Date:May 2, 2011TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Healthtrust
Novartis
Queensland Health
Boehringer Ingelheim
Chinese Patent Office
AstraZeneca
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot